These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19118315)

  • 1. Reports of esophageal cancer with oral bisphosphonate use.
    Wysowski DK
    N Engl J Med; 2009 Jan; 360(1):89-90. PubMed ID: 19118315
    [No Abstract]   [Full Text] [Related]  

  • 2. More on reports of esophageal cancer with oral bisphosphonate use.
    Shaheen NJ
    N Engl J Med; 2009 Apr; 360(17):1790-1; author reply 1791-2. PubMed ID: 19391257
    [No Abstract]   [Full Text] [Related]  

  • 3. More on reports of esophageal cancer with oral bisphosphonate use.
    Solomon DH; Patrick A; Brookhart MA
    N Engl J Med; 2009 Apr; 360(17):1789-90; author reply 1791-2. PubMed ID: 19391255
    [No Abstract]   [Full Text] [Related]  

  • 4. More on reports of esophageal cancer with oral bisphosphonate use.
    Hofbauer LC; Miehlke S
    N Engl J Med; 2009 Apr; 360(17):1790; author reply 1791-2. PubMed ID: 19391258
    [No Abstract]   [Full Text] [Related]  

  • 5. More on reports of esophageal cancer with oral bisphosphonate use.
    Abrahamsen B; Eiken P; Eastell R
    N Engl J Med; 2009 Apr; 360(17):1789; author reply 1791-2. PubMed ID: 19387022
    [No Abstract]   [Full Text] [Related]  

  • 6. More on reports of esophageal cancer with oral bisphosphonate use.
    Siris ES; Oster MW; Bilezikian JP
    N Engl J Med; 2009 Apr; 360(17):1791; author reply 1791-2. PubMed ID: 19391259
    [No Abstract]   [Full Text] [Related]  

  • 7. More on reports of esophageal cancer with oral bisphosphonate use.
    Robins HI; Holen KD
    N Engl J Med; 2009 Apr; 360(17):1790; author reply 1791-2. PubMed ID: 19391256
    [No Abstract]   [Full Text] [Related]  

  • 8. Alendronate and risk of esophageal cancer: a nationwide population-based study in Taiwan.
    Chen YM; Chen DY; Chen LK; Tsai YW; Chang LC; Huang WF; Chen LK; Liu CL; Chen YT; Hsiao FY
    J Am Geriatr Soc; 2011 Dec; 59(12):2379-81. PubMed ID: 22188086
    [No Abstract]   [Full Text] [Related]  

  • 9. An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.
    Haber SL; McNatty D
    Ann Pharmacother; 2012 Mar; 46(3):419-23. PubMed ID: 22333262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral bisphosphonates and oesophageal cancer.
    Wysowski DK
    BMJ; 2010 Sep; 341():c4506. PubMed ID: 20813821
    [No Abstract]   [Full Text] [Related]  

  • 11. Esophageal and gastric cancer incidence and mortality in alendronate users.
    Abrahamsen B; Pazianas M; Eiken P; Russell RG; Eastell R
    J Bone Miner Res; 2012 Mar; 27(3):679-86. PubMed ID: 22113985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
    Marx RE; Cillo JE; Ulloa JJ
    J Oral Maxillofac Surg; 2007 Dec; 65(12):2397-410. PubMed ID: 18022461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases.
    Wongchuensoontorn C; Liebehenschel N; Wagner K; Fakler O; Gutwald R; Schmelzeisen R; Sauerbier S
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1311-6. PubMed ID: 19446222
    [No Abstract]   [Full Text] [Related]  

  • 14. Is your knowledge up-to-date? Bisphosphonate-related osteonecrosis of the jaw.
    Barrow SY
    Int J Dent Hyg; 2008 Nov; 6(4):376-7. PubMed ID: 19138190
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
    Kunchur R; Need A; Hughes T; Goss A
    J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
    French DD; Margo CE
    Retina; 2008 Jun; 28(6):889-93. PubMed ID: 18536608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.
    Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons
    J Oral Maxillofac Surg; 2007 Mar; 65(3):369-76. PubMed ID: 17307580
    [No Abstract]   [Full Text] [Related]  

  • 18. An esophageal ulcer mimicking advanced esophageal cancer in a patient on alendronate sodium treatment for osteoporosis.
    Terashima T; Hiramatsu K; Shimatani A; Matsuda M; Ogino H; Satomura Y; Noda Y
    Endoscopy; 2006; 38 Suppl 2():E37. PubMed ID: 17366400
    [No Abstract]   [Full Text] [Related]  

  • 19. [Atrial fibrillation during bisphosphonate therapy. side effects or coincidental finding?].
    Ringe JD
    MMW Fortschr Med; 2009 Mar; 151(10):7. PubMed ID: 19472655
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diphosphonate therapy and osteonecrosis of the jaw].
    Løkken P; Skoglund LA; Skjelbred P
    Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.